Partners

Financial Only Feed

Only articles related to financial will show in this feed

Financial RSS

Financial Articles

Financial description coming soon.

Orthofix International to Participate in Morgan Stanley Unplugged Healthcare Conference

BOSTON–(BUSINESS WIRE)–Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today that it will participate in the Morgan Stanley Unplugged Healthcare Conference in New York City.

Chief Executive Officer Alan Milinazzo is scheduled to give a presentation on Monday,

September 13th, at 1:00 PM Eastern Time at the Grand Hyatt New York Hotel… Continue reading »

Orthofix International Establishes New $300 Million Credit Facility

BOSTON, Aug 31, 2010 (BUSINESS WIRE) — Orthofix International N.V. (OFIX 26.80, -0.28, -1.03%) (the Company) announced today that it has established a new $300 million five-year credit facility, including a $200 million senior secured revolving line of credit and a $100 million senior secured term loan. JP Morgan Chase Bank, N.A. acted as Sole… Continue reading »

Medtronic cuts 2011 guidance on weaker demand

Medtronic Inc., the world’s largest medical device maker, reported fiscal first–quarter earnings Tuesday in line with Wall Street expectations, but weaker global demand for medical implants forced the company to slash 2011 earnings expectations.

The Minneapolis–based company reported weaker–than–expected sales across all its major divisions, including heart–shocking defibrillators, pacemakers and spinal repair products… Continue reading »

Kensey Nash Posts 26% Q4 Profit Growth, But Shows Overall Profit Decline For Fiscal 2010

Kensey Nash (NASDAQ:KNSY), a medical device company that provides technologies for medical procedures, saw its fourth quarter profits for 2010 increase 25.6% year-over-year, while its profits for the entire fiscal year decreased by 3% on account of a decline in product sales.

The company reported profits of $5.9 million for the fourth quarter, or… Continue reading »

Osteotech Reports Second Quarter 2010 Financial Results

OSTEOTECH, INC. and SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(dollars in thousands, except per share data)

(unaudited)

Three Months

Six Months

Ending June 30,

Ending June 30,

2010
2009

TranS1 Inc. Reports Operating Results for the Second Quarter of 2010, Issues Third Quarter Guidance

WILMINGTON, N.C., Aug. 5, 2010 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region, today announced its financial results for the second quarter ended June 30, 2010… Continue reading »

NuVasive Reports Second Quarter 2010 Financial Results

SAN DIEGO, CA, Jul 27, 2010 (MARKETWIRE via COMTEX) —

NuVasive, Inc. (NASDAQ: NUVA)
– Total revenue of $119.6 million, up 35.2% over second quarter 2009
– GAAP earnings of $6.7 million, or $0.17 per share; Non-GAAP earnings
of $17.0 million, or $0.42 per share
– Non-GAAP operating margin of 15.8%, up from… Continue reading »

Orthopedic implant provider China Kanghui files for a $75 million IPO

China Kanghui Holdings, which is a leading China-based manufacturer and marketer of orthopedic implants, filed on Friday with the SEC to raise up to $75 million in an initial public offering. The Changzhou-based company, which was founded in 1997 and booked $29 million in sales over the last 12 months, plans to list on the… Continue reading »

Medical-Device Stocks Fall On Pricing, Market Growth Worries

Shares of medical-device makers fell Wednesday after some of the sector’s heavy hitters signaled ongoing struggles in top markets for orthopedic and heart devices, which face growth challenges and a persistent threat to product prices.

Second-quarter reports from Johnson & Johnson (JNJ) and Stryker Corp. (SYK) indicated the market for replacement hips and knees… Continue reading »

Zimmer 2Q Down 21% On Higher Charges; Masking Sales Growth

Zimmer Holdings Inc.’s (ZMH) second-quarter profit slid 21% on higher charges and lower margins, although the maker of orthopaedic products such as knee implants and spinal devices posted improved sales across nearly all regions and product lines.

Ahead of Zimmer’s report, results from a smaller rival Biomet Inc. sent positive signals about the health… Continue reading »

OsteoMed Posts 11% Growth

OsteoMed ended the 2nd quarter posting double digit (11%) YTD growth being fueled by the Small Bone Orthopedic business unit posting 14% YTD global growth (144% International). With the recent launch of OsteoMed’s FPS™ (foot plating system) and HPS™ (hand plating systems), the company expects growth to continue to accelerate.

For more information please contact, Tina Fernandez, Foot… Continue reading »

Orthopaedic Synergy Raises $2.73 Million

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM D

Orthofix International Announces Date For Release of Second Quarter Results

BOSTON–(BUSINESS WIRE)–Orthofix International N.V., (NASDAQ: OFIX) (the Company) announced today that it will host a conference call and webcast on Wednesday, July 28th, at 4:30 PM Eastern Time to discuss the Company’s results for the second quarter ended June 30, 2010, which will be released at approximately 4:00 PM Eastern that same day… Continue reading »

Medtronic paid CEO $9M in fiscal 2010

WASHINGTON — Medtronic Inc., the world’s largest medical device maker, paid Chief Executive William Hawkins $9 million in total compensation for fiscal 2010, roughly even with his earnings in the prior year, according to an analysis by the Associated Press.

Hawkins, 56, took the reins of Medtronic in 2008, replacing Art Collins, who had… Continue reading »

MEDICREA Group: Strong Sales Growth in the First Half

LYON, France–(BUSINESS WIRE)–The MEDICREA Group (Paris:ALMED)(listed on Alternext by NYSE Euronext Paris), a specialist in the design, manufacture and sale of spinal implants, is publishing its sales figures for the first half of 2010.

  • Sales up 32% from Q1 2010
  • Sales up 36% from Q2 2009
  • Q2 2010 was highest